ERENUMAB-AOOE

ERENUMAB-AOOE was reported 55567 times

ERENUMAB-AOOE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HEPATIC ENZYME 88 0.5906
1 HYPOCHOLESTEROLAEMIA 170 0.4816
2 FACET JOINT SYNDROME 924 0.2835
3 MIGRAINE-TRIGGERED SEIZURE 9 0.2195
4 PERIPHERAL VENOUS DISEASE 863 0.2111
5 NEOVASCULARISATION 50 0.1901
6 ONYCHOMADESIS 779 0.1854
7 BLEPHAROSPASM 1086 0.1723
8 RHEUMATIC FEVER 745 0.1670
9 LUPUS VULGARIS 201 0.1595
10 BREAST CANCER STAGE III 1024 0.1580
11 DEVICE DIFFICULT TO USE 10278 0.1551
12 OVERLAP SYNDROME 105 0.1500
13 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 1023 0.1426
14 INCORRECT DISPOSAL OF PRODUCT 459 0.1412
15 INTERCEPTED PRODUCT ADMINISTRATION ERROR 1024 0.1334
16 VASCULAR MALFORMATION 28 0.1333
17 DUODENAL ULCER PERFORATION 960 0.1290
18 ONYCHOMYCOSIS 535 0.1218
19 DISLOCATION OF VERTEBRA 276 0.1209
20 FOLLICULITIS 1232 0.1174
21 MUSCLE INJURY 969 0.1168
22 FINGER DEFORMITY 556 0.1147
23 PARANASAL CYST 27 0.1111
24 OCCUPATIONAL EXPOSURE TO PRODUCT 713 0.1108
25 NAIL DISORDER 970 0.1108
26 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 61 0.1087
27 DEEP VEIN THROMBOSIS POSTOPERATIVE 213 0.1063
28 POST-TRAUMATIC HEADACHE 16 0.1019
29 LIP DRY 913 0.1004
30 PEMPHIGUS 1253 0.1001
31 ACCIDENTAL EXPOSURE TO PRODUCT 10273 0.0996
32 VESTIBULAR MIGRAINE 24 0.0996
33 RETINITIS 165 0.0954
34 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 196 0.0945
35 WOUND INFECTION 1032 0.0941
36 HELICOBACTER INFECTION 968 0.0941
37 BURSITIS 1141 0.0939
38 LIVE BIRTH 761 0.0909
39 HYPERCHOLESTEROLAEMIA 877 0.0907
40 C-REACTIVE PROTEIN ABNORMAL 581 0.0905
41 PRODUCT LABEL CONFUSION 517 0.0886
42 INJECTION SITE INDENTATION 189 0.0872
43 DRUG DOSE OMISSION BY DEVICE 6743 0.0860
44 INFUSION SITE REACTION 257 0.0860
45 GRIP STRENGTH DECREASED 726 0.0824
46 HAND DEFORMITY 1063 0.0810
47 PRODUCT COMMUNICATION ISSUE 684 0.0775
48 BACK INJURY 836 0.0768
49 C-REACTIVE PROTEIN 70 0.0755
50 JOINT RANGE OF MOTION DECREASED 1011 0.0753
51 X-RAY ABNORMAL 127 0.0709
52 PERICARDITIS 1192 0.0709
53 HEMIPLEGIC MIGRAINE 24 0.0708
54 STATUS MIGRAINOSUS 11 0.0683
55 SYNOVITIS 1199 0.0664
56 PORPHYRIA ACUTE 89 0.0620
57 MEDICATION OVERUSE HEADACHE 52 0.0607
58 MIGRAINE WITHOUT AURA 18 0.0600
59 CERVICOGENIC HEADACHE 8 0.0588
60 POST CONCUSSION SYNDROME 20 0.0588
61 SWOLLEN JOINT COUNT INCREASED 187 0.0586
62 COELIAC DISEASE 563 0.0573
63 MIGRAINE 5427 0.0568
64 INCORRECT DOSE ADMINISTERED BY PRODUCT 89 0.0556
65 POST-TRAUMATIC NECK SYNDROME 44 0.0544
66 OBESITY 866 0.0543
67 GLOSSODYNIA 1211 0.0540
68 SOFT TISSUE INJURY 39 0.0515
69 IRRITABLE BOWEL SYNDROME 1099 0.0512
70 TASTE DISORDER 1004 0.0494
71 SWOLLEN JOINT COUNT 12 0.0480
72 ADVERSE REACTION 627 0.0472
73 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 9519 0.0469
74 BONE EROSION 157 0.0444
75 FIBROMYALGIA 1079 0.0443
76 RUBBER SENSITIVITY 64 0.0418
77 WOUND 1159 0.0414
78 RHEUMATOID FACTOR POSITIVE 235 0.0406
79 INCORRECT DOSE ADMINISTERED BY DEVICE 1063 0.0405
80 MYOCARDIAL OEDEMA 16 0.0405
81 LIVER FUNCTION TEST INCREASED 787 0.0366
82 EPILEPSY 1113 0.0364
83 LIVER INJURY 882 0.0359
84 MASTOIDITIS 35 0.0357
85 NORMAL NEWBORN 194 0.0357
86 GRIP STRENGTH 8 0.0349
87 SYSTEMIC LUPUS ERYTHEMATOSUS 1218 0.0343
88 PRODUCT STORAGE ERROR 2980 0.0340
89 TYPE 2 DIABETES MELLITUS 1133 0.0336
90 CONTRAINDICATED PRODUCT ADMINISTERED 1007 0.0332
91 OCCIPITAL NEURALGIA 18 0.0319
92 STERNAL FRACTURE 39 0.0316
93 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 21 0.0314
94 THERAPEUTIC PRODUCT EFFECT DECREASED 1395 0.0311
95 CONGENITAL ANOMALY 240 0.0310
96 GAIT INABILITY 1005 0.0300
97 IMPAIRED HEALING 981 0.0298
98 MIGRAINE WITH AURA 81 0.0298
99 BLOOD PRESSURE MEASUREMENT 19 0.0295
100 PSORIATIC ARTHROPATHY 1189 0.0293
101 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 989 0.0293
102 NIGHT SWEATS 940 0.0291
103 SERONEGATIVE ARTHRITIS 33 0.0288
104 INJURY ASSOCIATED WITH DEVICE 579 0.0284
105 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1996 0.0280
106 THERAPEUTIC RESPONSE SHORTENED 875 0.0264
107 C-REACTIVE PROTEIN INCREASED 956 0.0262
108 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 440 0.0256
109 DEVICE USE ERROR 888 0.0255
110 AUTOIMMUNE DISORDER 247 0.0253
111 OSTEOARTHRITIS 1064 0.0251
112 HEART RATE 8 0.0230
113 EXOSTOSIS 205 0.0224
114 BREAST CANCER STAGE II 186 0.0223
115 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 30 0.0222
116 DRUG TOLERANCE DECREASED 62 0.0221
117 AURA 41 0.0220
118 ULCER HAEMORRHAGE 148 0.0218
119 BLOOD CHOLESTEROL INCREASED 998 0.0214
120 JOINT DESTRUCTION 33 0.0212
121 CLUSTER HEADACHE 29 0.0212
122 LOWER RESPIRATORY TRACT INFECTION 960 0.0211
123 HEPATITIS 534 0.0208
124 THERAPEUTIC PRODUCT EFFECT DELAYED 92 0.0201
125 INFLAMMATION 1020 0.0197
126 PRESCRIBED OVERDOSE 378 0.0195
127 MATERNAL EXPOSURE TIMING UNSPECIFIED 73 0.0194
128 LIBIDO INCREASED 39 0.0192
129 ATRIOVENTRICULAR SEPTAL DEFECT 9 0.0191
130 LUNG DISORDER 934 0.0190
131 HEPATIC HAEMATOMA 9 0.0190
132 RED BLOOD CELL SEDIMENTATION RATE INCREASED 208 0.0188
133 NECK PAIN 1044 0.0187
134 DRUG-INDUCED LIVER INJURY 585 0.0186
135 ARTHROPATHY 1028 0.0185
136 WHEEZING 1073 0.0181
137 BLISTER 1013 0.0180
138 LOWER LIMB FRACTURE 344 0.0179
139 THERAPY NON-RESPONDER 804 0.0179
140 LUPUS-LIKE SYNDROME 162 0.0178
141 PUSTULAR PSORIASIS 61 0.0177
142 GASTROOESOPHAGEAL REFLUX DISEASE 1428 0.0177
143 INFUSION RELATED REACTION 1160 0.0175
144 PHONOPHOBIA 8 0.0174
145 MUSCULOSKELETAL PAIN 902 0.0172
146 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 110 0.0169
147 PRESCRIBED UNDERDOSE 335 0.0168
148 INTERCEPTED PRODUCT STORAGE ERROR 58 0.0162
149 PULMONARY FIBROSIS 305 0.0159
150 HEPATIC ENZYME INCREASED 1057 0.0155
151 STOMATITIS 940 0.0155
152 LACK OF INJECTION SITE ROTATION 27 0.0154
153 INJECTION SITE HYPOAESTHESIA 22 0.0154
154 MATERNAL EXPOSURE DURING PREGNANCY 1340 0.0150
155 DRUG TOLERANCE 76 0.0150
156 INJECTION SITE HAEMORRHAGE 1197 0.0150
157 HOSTILITY 38 0.0149
158 DRUG INTOLERANCE 1434 0.0148
159 CONSTIPATION 3196 0.0146
160 MOBILITY DECREASED 1052 0.0146
161 PERSONALITY DISORDER 38 0.0145
162 FEAR OF INJECTION 101 0.0141
163 PARADOXICAL DRUG REACTION 52 0.0141
164 CONCUSSION 109 0.0141
165 DEVICE ISSUE 1250 0.0139
166 PSYCHOGENIC SEIZURE 13 0.0139
167 INJURY 928 0.0132
168 LIQUID PRODUCT PHYSICAL ISSUE 96 0.0131
169 DRY MOUTH 1061 0.0131
170 RASH VESICULAR 63 0.0130
171 PRODUCT SUPPLY ISSUE 93 0.0130
172 UNDERDOSE 924 0.0126
173 SCIATICA 199 0.0125
174 INTENTIONAL PRODUCT USE ISSUE 1091 0.0124
175 SLEEP DISORDER 876 0.0124
176 SWELLING 1134 0.0121
177 PRODUCT TEMPERATURE EXCURSION ISSUE 62 0.0121
178 ALOPECIA 2331 0.0119
179 DRUG EFFECT INCOMPLETE 423 0.0116
180 INJECTION SITE REACTION 795 0.0115
181 OPHTHALMIC MIGRAINE 8 0.0115
182 PRODUCT ADMINISTRATION INTERRUPTED 89 0.0113
183 DYSPEPSIA 1113 0.0113
184 HYPOAESTHESIA 1689 0.0113
185 ILL-DEFINED DISORDER 676 0.0111
186 IMMUNISATION REACTION 8 0.0111
187 RHEUMATOID ARTHRITIS 1229 0.0108
188 EXPOSURE DURING PREGNANCY 664 0.0107
189 TENSION HEADACHE 45 0.0105
190 INJECTION SITE PARAESTHESIA 16 0.0104
191 INJECTION RELATED REACTION 17 0.0103
192 TREATMENT FAILURE 830 0.0100
193 MAST CELL ACTIVATION SYNDROME 14 0.0100
194 GENERAL PHYSICAL HEALTH DETERIORATION 1152 0.0099
195 SPONDYLITIS 36 0.0099
196 INJECTION SITE EXTRAVASATION 121 0.0098
197 MEMORY IMPAIRMENT 1345 0.0098
198 GASTROINTESTINAL DISORDER 866 0.0097
199 CRANIOCEREBRAL INJURY 29 0.0096
200 INJECTION SITE PAIN 2934 0.0096
201 SUSPECTED OFF LABEL USE 43 0.0095
202 JOINT SWELLING 1131 0.0094
203 TRICHORRHEXIS 26 0.0093
204 MUSCULOSKELETAL STIFFNESS 816 0.0093
205 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 435 0.0093
206 MUSCLE SPASMS 1681 0.0092
207 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 167 0.0091
208 OTITIS MEDIA 30 0.0091
209 PARAESTHESIA 1426 0.0091
210 EAR PAIN 175 0.0090
211 INJECTION SITE BRUISING 705 0.0088
212 DISCOMFORT 535 0.0088
213 INJECTION SITE DISCOMFORT 91 0.0086
214 EYE INJURY 26 0.0085
215 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 145 0.0085
216 JOINT DISLOCATION 90 0.0085
217 DEREALISATION 18 0.0084
218 NEEDLE ISSUE 242 0.0083
219 MUSCULAR WEAKNESS 940 0.0083
220 VESTIBULAR DISORDER 10 0.0082
221 DEVICE DEFECTIVE 141 0.0081
222 INJECTION SITE INJURY 45 0.0081
223 ABDOMINAL DISTENSION 842 0.0081
224 INJECTION SITE URTICARIA 197 0.0080
225 PANCREATIC FAILURE 14 0.0079
226 WALKING AID USER 50 0.0076
227 PERIPHERAL SWELLING 1167 0.0076
228 ABDOMINAL DISCOMFORT 1260 0.0075
229 HEPATIC CIRRHOSIS 141 0.0075
230 INJECTION SITE SCAR 21 0.0074
231 URTICARIA 1226 0.0073
232 ROAD TRAFFIC ACCIDENT 305 0.0073
233 CONFUSIONAL STATE 1178 0.0073
234 HYPERACUSIS 27 0.0072
235 DEVICE MALFUNCTION 507 0.0072
236 POLYARTHRITIS 38 0.0072
237 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 19 0.0071
238 DISABILITY 141 0.0071
239 HEAD DISCOMFORT 125 0.0071
240 HYPERTENSION 1482 0.0070
241 JOINT STIFFNESS 183 0.0070
242 INHIBITORY DRUG INTERACTION 11 0.0069
243 INTERCEPTED MEDICATION ERROR 32 0.0069
244 INJECTION SITE SWELLING 528 0.0069
245 ABDOMINAL PAIN UPPER 1413 0.0069
246 OBSTRUCTIVE SLEEP APNOEA SYNDROME 10 0.0069
247 WEIGHT INCREASED 1507 0.0067
248 BACK DISORDER 109 0.0067
249 ADVERSE EVENT 617 0.0067
250 OEDEMA 358 0.0066
251 PRODUCT PACKAGING ISSUE 62 0.0065
252 FIBROSIS 20 0.0065
253 EXPOSURE VIA SKIN CONTACT 167 0.0064
254 DEPRESSION 1464 0.0064
255 INJECTION SITE HYPERSENSITIVITY 20 0.0064
256 MYOSITIS 57 0.0063
257 SLEEP DEFICIT 13 0.0061
258 INJECTION SITE VESICLES 37 0.0061
259 PRODUCT QUALITY ISSUE 827 0.0061
260 NASOPHARYNGITIS 1121 0.0061
261 ANURIA 52 0.0060
262 PRODUCT ADMINISTRATION ERROR 122 0.0060
263 ARTERIOSPASM CORONARY 24 0.0060
264 TRIGEMINAL NEURALGIA 24 0.0060
265 FOOT DEFORMITY 66 0.0059
266 CEREBELLAR INFARCTION 10 0.0059
267 ASPARTATE AMINOTRANSFERASE ABNORMAL 9 0.0059
268 DELIRIUM 204 0.0059
269 HEADACHE 3684 0.0059
270 IMPAIRED GASTRIC EMPTYING 79 0.0058
271 HEART RATE ABNORMAL 32 0.0057
272 THERAPEUTIC RESPONSE DELAYED 16 0.0057
273 PRODUCT DOSE OMISSION 372 0.0057
274 BRAIN OPERATION 13 0.0057
275 INCORRECT PRODUCT ADMINISTRATION DURATION 123 0.0057
276 INJECTION SITE DISCOLOURATION 70 0.0056
277 DRUG DELIVERY SYSTEM ISSUE 11 0.0056
278 SINUS PAIN 13 0.0056
279 SNORING 21 0.0055
280 BRAIN INJURY 55 0.0055
281 FAECALOMA 30 0.0055
282 BODY TEMPERATURE ABNORMAL 10 0.0054
283 CEREBROSPINAL FLUID LEAKAGE 10 0.0054
284 PRODUCT DISPENSING ERROR 116 0.0053
285 PHOTOPHOBIA 100 0.0053
286 SEIZURE LIKE PHENOMENA 9 0.0053
287 EAR INFECTION 141 0.0053
288 DRUG EFFECT DELAYED 24 0.0053
289 VERTIGO 321 0.0053
290 CONTUSION 507 0.0053
291 GASTROINTESTINAL MOTILITY DISORDER 28 0.0052
292 PRODUCT PREPARATION ERROR 107 0.0052
293 GENERAL SYMPTOM 39 0.0052
294 PRODUCT USE IN UNAPPROVED INDICATION 1287 0.0052
295 MENOPAUSAL SYMPTOMS 12 0.0052
296 OSTEOPOROSIS 210 0.0051
297 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 245 0.0051
298 TINNITUS 233 0.0051
299 MENSTRUAL DISORDER 42 0.0051
300 INJECTION SITE RASH 155 0.0050
301 NASAL ULCER 8 0.0050
302 GASTROINTESTINAL OBSTRUCTION 12 0.0050
303 COMMUNICATION DISORDER 19 0.0050
304 HYPERSENSITIVITY 918 0.0049
305 SPINAL FUSION SURGERY 20 0.0049
306 COLITIS ISCHAEMIC 33 0.0049
307 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 268 0.0049
308 GASTROINTESTINAL HYPOMOTILITY 11 0.0049
309 PRODUCT USE ISSUE 891 0.0047
310 AMNESIA 305 0.0047
311 ASPIRATION 51 0.0047
312 MUSCLE TWITCHING 107 0.0046
313 GASTRIC BYPASS 10 0.0046
314 PRODUCT CONTAINER SEAL ISSUE 8 0.0046
315 DYSCHEZIA 14 0.0046
316 OLIGOMENORRHOEA 10 0.0046
317 ADVERSE DRUG REACTION 411 0.0046
318 HIP ARTHROPLASTY 69 0.0045
319 INSOMNIA 1197 0.0045
320 DEVICE FAILURE 68 0.0045
321 AUTONOMIC NERVOUS SYSTEM IMBALANCE 13 0.0044
322 EAR CONGESTION 12 0.0044
323 BRAIN FOG 69 0.0044
324 CLUMSINESS 12 0.0044
325 OESOPHAGEAL SPASM 8 0.0043
326 ARTHRALGIA 1799 0.0043
327 VISUAL FIELD DEFECT 31 0.0043
328 INJECTION SITE ERYTHEMA 532 0.0043
329 PHARYNGEAL ERYTHEMA 9 0.0042
330 CONDITION AGGRAVATED 1289 0.0042
331 APHASIA 128 0.0042
332 RESPIRATORY DISORDER 126 0.0042
333 THERAPY PARTIAL RESPONDER 65 0.0042
334 THERAPEUTIC PRODUCT EFFECT VARIABLE 16 0.0041
335 PHOTOPSIA 26 0.0041
336 COLONOSCOPY 9 0.0041
337 INJECTION SITE WARMTH 84 0.0041
338 DIZZINESS 2028 0.0041
339 IMMUNODEFICIENCY 60 0.0040
340 INJECTION SITE PRURITUS 268 0.0040
341 HYPOAESTHESIA ORAL 60 0.0040
342 INJECTION SITE MASS 147 0.0040
343 ELECTRIC SHOCK SENSATION 11 0.0039
344 INJECTION SITE IRRITATION 50 0.0039
345 FACIAL PAIN 35 0.0039
346 CEREBRAL DISORDER 29 0.0039
347 BOWEL MOVEMENT IRREGULARITY 30 0.0039
348 ROSACEA 18 0.0039
349 PAIN IN EXTREMITY 1135 0.0038
350 LIVER DISORDER 170 0.0038
351 GASTROINTESTINAL PAIN 42 0.0038
352 FREQUENT BOWEL MOVEMENTS 103 0.0038
353 POOR QUALITY SLEEP 82 0.0038
354 VOLVULUS 9 0.0038
355 ALANINE AMINOTRANSFERASE ABNORMAL 8 0.0038
356 INCORRECT DOSE ADMINISTERED 860 0.0038
357 THERAPY INTERRUPTED 269 0.0038
358 SINUSITIS 385 0.0038
359 NECK INJURY 11 0.0037
360 DECREASED APPETITE 870 0.0037
361 SHOULDER OPERATION 16 0.0037
362 TEMPOROMANDIBULAR JOINT SYNDROME 10 0.0037
363 PULSE ABNORMAL 9 0.0037
364 INFLUENZA LIKE ILLNESS 307 0.0037
365 INFUSION SITE BRUISING 8 0.0037
366 AUTOIMMUNE THYROIDITIS 14 0.0037
367 HORMONE LEVEL ABNORMAL 18 0.0037
368 RASH 1606 0.0037
369 FEELING HOT 224 0.0037
370 PANIC ATTACK 131 0.0036
371 THERAPEUTIC RESPONSE UNEXPECTED 161 0.0036
372 FOOD INTOLERANCE 13 0.0035
373 PRODUCT CONTAMINATION PHYSICAL 9 0.0035
374 INCORRECT DRUG ADMINISTRATION RATE 15 0.0035
375 MENOPAUSE 9 0.0035
376 VOMITING 1639 0.0035
377 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 627 0.0035
378 PHARYNGEAL SWELLING 34 0.0035
379 HYPERTRANSAMINASAEMIA 24 0.0034
380 ASTHENIA 1295 0.0034
381 SEROTONIN SYNDROME 66 0.0034
382 PARANASAL SINUS DISCOMFORT 13 0.0034
383 DRUG INEFFECTIVE 4511 0.0034
384 KNEE ARTHROPLASTY 72 0.0034
385 PAIN 2098 0.0034
386 MUSCLE TIGHTNESS 55 0.0034
387 TEMPERATURE INTOLERANCE 35 0.0034
388 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO DEVICE USE ERROR 8 0.0034
389 PANIC DISORDER 13 0.0034
390 OFF LABEL USE 2925 0.0033
391 LIMB OPERATION 16 0.0033
392 BREAST PAIN 35 0.0033
393 PARAESTHESIA ORAL 47 0.0033
394 ASTHMA 367 0.0032
395 NAUSEA 2559 0.0032
396 MATERNAL EXPOSURE BEFORE PREGNANCY 22 0.0032
397 INJECTION SITE INFLAMMATION 16 0.0032
398 BEDRIDDEN 42 0.0032
399 PNEUMONIA 1033 0.0032
400 FACIAL PARALYSIS 27 0.0032
401 VISUAL IMPAIRMENT 390 0.0031
402 AMENORRHOEA 55 0.0031
403 RED CELL DISTRIBUTION WIDTH INCREASED 13 0.0031
404 NEURALGIA 76 0.0031
405 TYPE I HYPERSENSITIVITY 11 0.0031
406 DRUG EFFECT DECREASED 168 0.0031
407 FATIGUE 2422 0.0031
408 DISTURBANCE IN ATTENTION 167 0.0031
409 MALAISE 1358 0.0031
410 PREGNANCY 62 0.0031
411 CHEST PAIN 573 0.0031
412 FAECES HARD 12 0.0031
413 ANTINUCLEAR ANTIBODY POSITIVE 10 0.0031
414 INJECTION SITE PAPULE 14 0.0031
415 PERIPHERAL COLDNESS 42 0.0031
416 WEIGHT FLUCTUATION 32 0.0031
417 INTRACRANIAL PRESSURE INCREASED 17 0.0030
418 FEELING ABNORMAL 724 0.0030
419 ANEURYSM 15 0.0030
420 ANIMAL BITE 8 0.0030
421 MIDDLE INSOMNIA 56 0.0030
422 BODY TEMPERATURE INCREASED 61 0.0030
423 ABDOMINAL MASS 8 0.0030
424 ANXIETY 845 0.0030
425 HEPATIC CYST 10 0.0029
426 NEPHROPATHY TOXIC 33 0.0029
427 SPINAL OPERATION 36 0.0029
428 ILEUS PARALYTIC 13 0.0029
429 RASH PRURITIC 157 0.0029
430 TROPONIN INCREASED 22 0.0029
431 DEPRESSION SUICIDAL 10 0.0029
432 POLYMENORRHOEA 10 0.0029
433 FALL 959 0.0029
434 BLOOD PRESSURE ABNORMAL 57 0.0029
435 FOETAL EXPOSURE DURING PREGNANCY 233 0.0029
436 FOOD ALLERGY 22 0.0028
437 PALPITATIONS 333 0.0028
438 POST-TRAUMATIC STRESS DISORDER 19 0.0028
439 ADRENAL INSUFFICIENCY 34 0.0028
440 EXPOSURE VIA BREAST MILK 11 0.0028
441 CONCOMITANT DISEASE AGGRAVATED 17 0.0028
442 SCLERODERMA 10 0.0027
443 ABORTION 8 0.0027
444 THERAPEUTIC RESPONSE DECREASED 165 0.0027
445 UPPER RESPIRATORY TRACT INFECTION 125 0.0027
446 RHINITIS ALLERGIC 12 0.0027
447 SINUS HEADACHE 16 0.0027
448 INTENTIONAL PRODUCT MISUSE 234 0.0027
449 EMERGENCY CARE 8 0.0026
450 PRURITUS GENERALISED 57 0.0026
451 EAR DISCOMFORT 27 0.0026
452 RIB FRACTURE 54 0.0026
453 GASTROINTESTINAL SOUNDS ABNORMAL 13 0.0026
454 DEVICE PHYSICAL PROPERTY ISSUE 20 0.0026
455 INJECTION SITE DISCHARGE 14 0.0026
456 MUSCLE FATIGUE 11 0.0026
457 FEELING DRUNK 19 0.0026
458 FLUID RETENTION 130 0.0026
459 MULTIPLE ALLERGIES 20 0.0025
460 CATARACT OPERATION 15 0.0025
461 ABDOMINAL PAIN 588 0.0025
462 NEPHROLITHIASIS 115 0.0025
463 PANIC REACTION 18 0.0025
464 SURGERY 146 0.0025
465 SENSITIVITY TO WEATHER CHANGE 13 0.0025
466 NIGHTMARE 85 0.0025
467 ANAL INCONTINENCE 22 0.0024
468 DEAFNESS NEUROSENSORY 8 0.0024
469 DRUG EFFECT LESS THAN EXPECTED 36 0.0024
470 IMMUNE SYSTEM DISORDER 32 0.0024
471 ABNORMAL DREAMS 67 0.0024
472 LYME DISEASE 8 0.0024
473 TENDERNESS 25 0.0024
474 INJECTION SITE INDURATION 31 0.0024
475 INTESTINAL OBSTRUCTION 90 0.0024
476 QUALITY OF LIFE DECREASED 32 0.0024
477 MYALGIA 405 0.0024
478 IMPAIRED DRIVING ABILITY 27 0.0024
479 JAW DISORDER 13 0.0024
480 BLOOD PRESSURE INCREASED 361 0.0024
481 ILLNESS 242 0.0023
482 PANCREATITIS 124 0.0023
483 OROPHARYNGEAL DISCOMFORT 21 0.0023
484 INFECTION 334 0.0023
485 AORTIC STENOSIS 8 0.0023
486 AFFECTIVE DISORDER 18 0.0023
487 BRAIN NEOPLASM 21 0.0023
488 DYSPNOEA 1293 0.0023
489 HEAD INJURY 72 0.0023
490 PAROSMIA 17 0.0023
491 SEDATION 59 0.0023
492 HAEMORRHAGIC DIATHESIS 8 0.0022
493 INTRACRANIAL ANEURYSM 9 0.0022
494 FOOD POISONING 12 0.0022
495 COGNITIVE DISORDER 104 0.0022
496 PAPILLOEDEMA 10 0.0022
497 RECTAL HAEMORRHAGE 94 0.0022
498 UPPER-AIRWAY COUGH SYNDROME 18 0.0022
499 HEART RATE INCREASED 215 0.0022
500 CARDIAC FLUTTER 14 0.0022
501 DIARRHOEA 1394 0.0022
502 PETIT MAL EPILEPSY 11 0.0022
503 MENSTRUATION IRREGULAR 57 0.0021
504 FEEDING DISORDER 43 0.0021
505 SEASONAL ALLERGY 30 0.0021
506 SUICIDAL IDEATION 194 0.0021
507 SKIN ABRASION 10 0.0021
508 INTERVERTEBRAL DISC DISORDER 9 0.0021
509 PRE-EXISTING CONDITION IMPROVED 13 0.0021
510 BRONCHITIS 154 0.0021
511 PRODUCT LABEL ISSUE 14 0.0021
512 EXTRAPYRAMIDAL DISORDER 51 0.0021
513 OCULAR DISCOMFORT 23 0.0020
514 COLD SWEAT 36 0.0020
515 COLITIS ULCERATIVE 90 0.0020
516 PHOTOSENSITIVITY REACTION 33 0.0020
517 PAPULE 14 0.0020
518 GASTRIC DISORDER 68 0.0020
519 FRUSTRATION TOLERANCE DECREASED 16 0.0020
520 MENTAL DISORDER 86 0.0020
521 HYPERSOMNIA 56 0.0020
522 OEDEMA PERIPHERAL 238 0.0020
523 DYSARTHRIA 73 0.0019
524 PRESYNCOPE 47 0.0019
525 FEELING OF DESPAIR 9 0.0019
526 WHITE BLOOD CELL COUNT INCREASED 74 0.0019
527 VENTRICULAR EXTRASYSTOLES 20 0.0019
528 SINUS DISORDER 38 0.0019
529 IMPAIRED WORK ABILITY 41 0.0019
530 TREMOR 317 0.0019
531 GAIT DISTURBANCE 365 0.0019
532 ATTENTION DEFICIT HYPERACTIVITY DISORDER 8 0.0019
533 LOSS OF CONSCIOUSNESS 243 0.0019
534 FEELING JITTERY 36 0.0019
535 ENDOMETRIOSIS 9 0.0019
536 SEIZURE 218 0.0019
537 RENAL PAIN 20 0.0019
538 THROAT TIGHTNESS 51 0.0019
539 WEIGHT DECREASED 523 0.0019
540 SCAR 32 0.0019
541 ENERGY INCREASED 11 0.0019
542 ABNORMAL SENSATION IN EYE 8 0.0019
543 SKIN CANCER 40 0.0019
544 PAIN OF SKIN 50 0.0019
545 MENTAL IMPAIRMENT 45 0.0019
546 MEDICATION ERROR 103 0.0019
547 DIPLOPIA 48 0.0018
548 INCREASED TENDENCY TO BRUISE 17 0.0018
549 PRURITUS 708 0.0018
550 NERVE COMPRESSION 17 0.0018
551 INSURANCE ISSUE 28 0.0018
552 IRRITABILITY 110 0.0018
553 THINKING ABNORMAL 34 0.0018
554 DYSPHEMIA 8 0.0018
555 TOOTHACHE 33 0.0018
556 FOOT OPERATION 9 0.0018
557 HOT FLUSH 137 0.0018
558 CORONAVIRUS INFECTION 12 0.0018
559 DEAFNESS UNILATERAL 10 0.0018
560 ARTHRITIS 142 0.0018
561 SCRATCH 19 0.0018
562 OVARIAN CYST 18 0.0018
563 EYE PAIN 101 0.0018
564 SLEEP APNOEA SYNDROME 34 0.0018
565 ILEUS 22 0.0018
566 CHEST DISCOMFORT 181 0.0018
567 BLOOD THYROID STIMULATING HORMONE DECREASED 8 0.0018
568 BLOOD PRESSURE SYSTOLIC DECREASED 8 0.0018
569 INFUSION SITE SWELLING 11 0.0017
570 DYSSTASIA 51 0.0017
571 SARS-COV-2 TEST POSITIVE 23 0.0017
572 THERAPY CHANGE 17 0.0017
573 SKIN SWELLING 15 0.0017
574 LIGAMENT SPRAIN 17 0.0017
575 SKIN WARM 10 0.0017
576 LIMB DISCOMFORT 53 0.0017
577 ANGINA PECTORIS 49 0.0017
578 IMMUNOSUPPRESSION 15 0.0017
579 MULTIPLE SCLEROSIS 81 0.0017
580 KIDNEY INFECTION 33 0.0017
581 ACCIDENT 20 0.0017
582 HYPERHIDROSIS 214 0.0017
583 MENSTRUATION DELAYED 18 0.0017
584 BIPOLAR DISORDER 18 0.0017
585 FEELING COLD 46 0.0017
586 RESTLESS LEGS SYNDROME 30 0.0016
587 ABORTION SPONTANEOUS 66 0.0016
588 RESPIRATORY TRACT CONGESTION 26 0.0016
589 FOOT FRACTURE 31 0.0016
590 DECREASED IMMUNE RESPONSIVENESS 16 0.0016
591 SENSITIVE SKIN 12 0.0016
592 KNEE OPERATION 16 0.0016
593 VISION BLURRED 222 0.0016
594 DYSGEUSIA 120 0.0016
595 HEPATIC ENZYME ABNORMAL 8 0.0016
596 ANKYLOSING SPONDYLITIS 21 0.0016
597 VIRAL INFECTION 53 0.0016
598 HAIR GROWTH ABNORMAL 11 0.0016
599 METRORRHAGIA 27 0.0016
600 HYPERAESTHESIA 13 0.0016
601 FORMICATION 11 0.0016
602 NEUROLOGICAL SYMPTOM 9 0.0016
603 PHARYNGITIS STREPTOCOCCAL 17 0.0016
604 SWELLING FACE 102 0.0016
605 TACHYCARDIA 139 0.0016
606 HERPES VIRUS INFECTION 9 0.0016
607 GASTROINTESTINAL INFECTION 14 0.0016
608 RASH PAPULAR 35 0.0016
609 PRODUCT DOSE OMISSION ISSUE 459 0.0016
610 MOUTH SWELLING 9 0.0016
611 PAIN IN JAW 44 0.0016
612 HAND FRACTURE 11 0.0016
613 GASTROENTERITIS VIRAL 28 0.0015
614 APHTHOUS ULCER 12 0.0015
615 MOOD SWINGS 49 0.0015
616 FEELING OF BODY TEMPERATURE CHANGE 9 0.0015
617 IMPAIRED QUALITY OF LIFE 22 0.0015
618 MUSCULOSKELETAL DISORDER 29 0.0015
619 DYSMENORRHOEA 20 0.0015
620 GINGIVAL PAIN 12 0.0015
621 NYSTAGMUS 8 0.0015
622 RASH GENERALISED 39 0.0015
623 MAJOR DEPRESSION 11 0.0015
624 APHONIA 21 0.0015
625 ANAPHYLACTIC REACTION 83 0.0015
626 BURNING SENSATION 105 0.0015
627 LETHARGY 86 0.0015
628 DEPRESSED MOOD 79 0.0015
629 BLINDNESS TRANSIENT 11 0.0015
630 LABORATORY TEST ABNORMAL 44 0.0015
631 SENSORY LOSS 12 0.0015
632 INFLUENZA 166 0.0015
633 MYASTHENIA GRAVIS 12 0.0015
634 ARTHROPOD BITE 11 0.0015
635 LYMPHADENOPATHY 52 0.0015
636 FLATULENCE 83 0.0015
637 NASAL CONGESTION 86 0.0015
638 PSORIASIS 191 0.0015
639 BREAST TENDERNESS 11 0.0015
640 EYE DISORDER 48 0.0015
641 BALANCE DISORDER 126 0.0015
642 ONYCHOCLASIS 10 0.0015
643 MUSCULOSKELETAL DISCOMFORT 25 0.0015
644 COVID-19 254 0.0014
645 EXPIRED PRODUCT ADMINISTERED 48 0.0014
646 TOOTH INFECTION 19 0.0014
647 SWOLLEN TONGUE 45 0.0014
648 CEREBROVASCULAR ACCIDENT 244 0.0014
649 SWELLING OF EYELID 9 0.0014
650 EXTRASYSTOLES 10 0.0014
651 TRANSIENT ISCHAEMIC ATTACK 48 0.0014
652 SKIN REACTION 20 0.0014
653 SPEECH DISORDER 74 0.0014
654 SINUS CONGESTION 19 0.0014
655 SOMNOLENCE 283 0.0014
656 INTERVERTEBRAL DISC DEGENERATION 13 0.0014
657 PRODUCT DISTRIBUTION ISSUE 13 0.0014
658 GALACTORRHOEA 9 0.0014
659 DEPRESSED LEVEL OF CONSCIOUSNESS 55 0.0014
660 MUSCLE STRAIN 12 0.0014
661 HYSTERECTOMY 12 0.0014
662 PYREXIA 477 0.0014
663 FLUSHING 140 0.0014
664 STRESS CARDIOMYOPATHY 8 0.0014
665 SLUGGISHNESS 14 0.0014
666 HOSPITALISATION 210 0.0014
667 HEMIPARESIS 23 0.0014
668 DECREASED INTEREST 8 0.0014
669 POST PROCEDURAL COMPLICATION 26 0.0014
670 EYE SWELLING 50 0.0013
671 RESPIRATORY TRACT INFECTION 35 0.0013
672 THIRST 24 0.0013
673 ABNORMAL FAECES 11 0.0013
674 ACCIDENTAL OVERDOSE 49 0.0013
675 SYMPTOM RECURRENCE 8 0.0013
676 GASTRITIS 35 0.0013
677 MENORRHAGIA 26 0.0013
678 INFUSION SITE PAIN 17 0.0013
679 UNEVALUABLE EVENT 99 0.0013
680 UPPER LIMB FRACTURE 26 0.0013
681 PRODUCT PRESCRIBING ERROR 31 0.0013
682 MENISCUS INJURY 8 0.0013
683 ENCEPHALITIS 9 0.0013
684 SMALL INTESTINAL OBSTRUCTION 16 0.0013
685 INTENTIONAL DOSE OMISSION 37 0.0013
686 LOW DENSITY LIPOPROTEIN INCREASED 10 0.0013
687 LIP SWELLING 43 0.0013
688 SYNCOPE 129 0.0013
689 SKIN LACERATION 14 0.0013
690 INFUSION SITE EXTRAVASATION 8 0.0013
691 APPENDICITIS 12 0.0013
692 EYELID PTOSIS 13 0.0013
693 RETCHING 27 0.0013
694 DIVERTICULITIS 35 0.0013
695 HYPOACUSIS 54 0.0013
696 SUPRAVENTRICULAR TACHYCARDIA 12 0.0013
697 OROPHARYNGEAL PAIN 116 0.0013
698 SPINAL OSTEOARTHRITIS 11 0.0013
699 WRIST FRACTURE 15 0.0013
700 SENSORY DISTURBANCE 20 0.0012
701 HERPES ZOSTER 71 0.0012
702 MUSCLE DISORDER 10 0.0012
703 THYROID DISORDER 19 0.0012
704 BACK PAIN 286 0.0012
705 VITAMIN D DEFICIENCY 12 0.0012
706 ANKLE FRACTURE 19 0.0012
707 MASS 17 0.0012
708 SKIN HAEMORRHAGE 18 0.0012
709 BLADDER DISORDER 12 0.0012
710 SNEEZING 27 0.0012
711 HAIR TEXTURE ABNORMAL 16 0.0012
712 DERMATITIS ALLERGIC 15 0.0012
713 INTERVERTEBRAL DISC PROTRUSION 26 0.0012
714 PERSONALITY CHANGE 11 0.0012
715 TOOTH FRACTURE 13 0.0012
716 RESTLESSNESS 43 0.0012
717 HYPERTHYROIDISM 17 0.0012
718 PROCEDURAL COMPLICATION 9 0.0012
719 INITIAL INSOMNIA 12 0.0012
720 NERVE INJURY 13 0.0012
721 HYPERTENSIVE CRISIS 13 0.0012
722 RESPIRATION ABNORMAL 8 0.0012
723 GENERALISED TONIC-CLONIC SEIZURE 19 0.0011
724 ELECTROCARDIOGRAM ABNORMAL 9 0.0011
725 AFFECT LABILITY 11 0.0011
726 DRY EYE 57 0.0011
727 GROIN PAIN 10 0.0011
728 MICTURITION URGENCY 13 0.0011
729 MOOD ALTERED 31 0.0011
730 OVERDOSE 245 0.0011
731 ULCER 18 0.0011
732 OBSESSIVE-COMPULSIVE DISORDER 9 0.0011
733 NERVOUS SYSTEM DISORDER 35 0.0011
734 ARRHYTHMIA 53 0.0011
735 VITREOUS FLOATERS 11 0.0011
736 DECREASED ACTIVITY 12 0.0011
737 BLOOD THYROID STIMULATING HORMONE INCREASED 10 0.0011
738 DISORIENTATION 43 0.0011
739 DEVICE LEAKAGE 47 0.0011
740 MOTOR DYSFUNCTION 11 0.0011
741 NERVOUSNESS 56 0.0011
742 THERAPY CESSATION 55 0.0011
743 CANDIDA INFECTION 18 0.0011
744 PRODUCT DOSE OMISSION IN ERROR 30 0.0011
745 PARALYSIS 15 0.0010
746 INCREASED APPETITE 20 0.0010
747 CRYING 38 0.0010
748 TOOTH EXTRACTION 13 0.0010
749 POOR QUALITY PRODUCT ADMINISTERED 11 0.0010
750 DISSOCIATION 8 0.0010
751 EATING DISORDER 22 0.0010
752 ORAL HERPES 20 0.0010
753 DEVICE DELIVERY SYSTEM ISSUE 28 0.0010
754 INFLAMMATORY BOWEL DISEASE 10 0.0010
755 HEART RATE IRREGULAR 23 0.0010
756 PRODUCT USE COMPLAINT 16 0.0010
757 ORAL DISCOMFORT 14 0.0010
758 HEAVY MENSTRUAL BLEEDING 9 0.0010
759 OPTIC NEURITIS 9 0.0010
760 SUBARACHNOID HAEMORRHAGE 10 0.0010
761 BLINDNESS 40 0.0010
762 SKIN DISCOLOURATION 45 0.0010
763 HYPOTENSION 196 0.0010
764 COUGH 274 0.0010
765 ELECTROCARDIOGRAM QT PROLONGED 35 0.0010
766 CARDIAC DISORDER 91 0.0010
767 CHILLS 113 0.0010
768 CHOLECYSTECTOMY 11 0.0010
769 RASH ERYTHEMATOUS 46 0.0010
770 HEMIPLEGIA 8 0.0010
771 FUNGAL INFECTION 32 0.0010
772 LIMB INJURY 26 0.0010
773 DEAFNESS 25 0.0010
774 ISCHAEMIC STROKE 17 0.0010
775 SENSATION OF FOREIGN BODY 8 0.0009
776 INFUSION SITE ERYTHEMA 8 0.0009
777 INCONTINENCE 10 0.0009
778 NEOPLASM MALIGNANT 63 0.0009
779 RASH MACULAR 33 0.0009
780 SPINAL PAIN 11 0.0009
781 HYPOPHAGIA 24 0.0009
782 HEREDITARY ANGIOEDEMA 10 0.0009
783 CARDIAC OPERATION 8 0.0009
784 CARPAL TUNNEL SYNDROME 13 0.0009
785 BLOOD PRESSURE SYSTOLIC INCREASED 18 0.0009
786 HAEMORRHOIDS 18 0.0009
787 THROAT IRRITATION 41 0.0009
788 EXTRA DOSE ADMINISTERED 37 0.0009
789 HEPATIC STEATOSIS 17 0.0009
790 HEART RATE DECREASED 32 0.0009
791 BRONCHOSPASM 13 0.0009
792 DYSKINESIA 37 0.0009
793 URINARY TRACT INFECTION 155 0.0009
794 BLOOD PRESSURE DECREASED 60 0.0009
795 ERECTILE DYSFUNCTION 23 0.0009
796 APATHY 13 0.0009
797 GLAUCOMA 17 0.0009
798 RHINORRHOEA 57 0.0009
799 GINGIVAL BLEEDING 12 0.0009
800 EMOTIONAL DISORDER 27 0.0009
801 ABDOMINAL PAIN LOWER 22 0.0009
802 POOR VENOUS ACCESS 9 0.0009
803 HUNGER 12 0.0009
804 SPINAL DISORDER 8 0.0008
805 NODULE 11 0.0008
806 PRODUCT PHYSICAL ISSUE 17 0.0008
807 GASTRIC ULCER 16 0.0008
808 MYOCARDIAL INFARCTION 146 0.0008
809 BONE PAIN 49 0.0008
810 ORAL CANDIDIASIS 11 0.0008
811 PREMATURE BABY 25 0.0008
812 ERYTHEMA 170 0.0008
813 DIZZINESS POSTURAL 8 0.0008
814 FEAR 22 0.0008
815 ANAPHYLACTIC SHOCK 21 0.0008
816 DIABETES MELLITUS 62 0.0008
817 HYPOKALAEMIA 37 0.0008
818 SECRETION DISCHARGE 10 0.0008
819 JOINT INJURY 17 0.0008
820 BLOOD PRESSURE FLUCTUATION 19 0.0008
821 COLITIS 30 0.0008
822 DERMATITIS CONTACT 9 0.0008
823 INTERNAL HAEMORRHAGE 9 0.0008
824 LOCALISED INFECTION 19 0.0008
825 CYSTITIS 25 0.0008
826 PRODUCT PRESCRIBING ISSUE 17 0.0008
827 BLINDNESS UNILATERAL 11 0.0008
828 MOVEMENT DISORDER 25 0.0008
829 NEUROPATHY PERIPHERAL 74 0.0008
830 VASCULITIS 9 0.0008
831 HIATUS HERNIA 10 0.0008
832 SEXUAL DYSFUNCTION 9 0.0008
833 LEUKOPENIA 38 0.0008
834 DEMENTIA 21 0.0008
835 BLOOD SODIUM DECREASED 14 0.0007
836 BLOOD POTASSIUM DECREASED 22 0.0007
837 TREATMENT NONCOMPLIANCE 40 0.0007
838 ANGIOEDEMA 32 0.0007
839 TRANSAMINASES INCREASED 16 0.0007
840 SKIN DISORDER 24 0.0007
841 TOOTH DISORDER 16 0.0007
842 DYSPHONIA 42 0.0007
843 ORAL PAIN 16 0.0007
844 BLOOD TEST ABNORMAL 10 0.0007
845 MUSCLE ATROPHY 9 0.0007
846 URINARY INCONTINENCE 21 0.0007
847 NEOPLASM 8 0.0007
848 VAGINAL HAEMORRHAGE 30 0.0007
849 CLOSTRIDIUM DIFFICILE INFECTION 15 0.0007
850 AGEUSIA 17 0.0007
851 ANGER 23 0.0007
852 COVID-19 PNEUMONIA 8 0.0007
853 POLLAKIURIA 28 0.0007
854 MANIA 11 0.0007
855 MOUTH ULCERATION 14 0.0007
856 BRADYCARDIA 35 0.0007
857 SKIN LESION 18 0.0007
858 BREAST CANCER 61 0.0007
859 DYSPHAGIA 62 0.0007
860 CARDIOMEGALY 8 0.0006
861 PHARYNGEAL OEDEMA 10 0.0006
862 TENDON RUPTURE 8 0.0006
863 TENDONITIS 10 0.0006
864 CYST 8 0.0006
865 ACUTE MYOCARDIAL INFARCTION 19 0.0006
866 CEREBRAL HAEMORRHAGE 23 0.0006
867 BLOOD URINE PRESENT 12 0.0006
868 DRUG INTERACTION 100 0.0006
869 HALLUCINATION, AUDITORY 10 0.0006
870 URINARY RETENTION 21 0.0006
871 LACRIMATION INCREASED 19 0.0006
872 PRODUCTIVE COUGH 30 0.0006
873 HYPOTHYROIDISM 20 0.0006
874 NO ADVERSE EVENT 113 0.0006
875 DYSTONIA 12 0.0006
876 CHOKING 12 0.0006
877 PRODUCT AVAILABILITY ISSUE 14 0.0006
878 PULMONARY EMBOLISM 58 0.0006
879 DEHYDRATION 81 0.0006
880 PELVIC PAIN 11 0.0006
881 EPISTAXIS 45 0.0006
882 DYSURIA 22 0.0006
883 PRODUCT COMPLAINT 15 0.0006
884 AKATHISIA 8 0.0006
885 PARANOIA 10 0.0006
886 PROCEDURAL PAIN 16 0.0006
887 PULMONARY HYPERTENSION 12 0.0006
888 STAPHYLOCOCCAL INFECTION 19 0.0006
889 DERMATITIS 12 0.0006
890 WITHDRAWAL SYNDROME 24 0.0006
891 EYE PRURITUS 19 0.0006
892 SKIN FISSURES 11 0.0006
893 HAEMATOCHEZIA 31 0.0006
894 GALLBLADDER DISORDER 10 0.0006
895 EYE IRRITATION 32 0.0006
896 CATARACT 33 0.0006
897 HAEMATEMESIS 14 0.0006
898 HYPOKINESIA 8 0.0006
899 THROMBOSIS 43 0.0005
900 DEATH 458 0.0005
901 HALLUCINATION 40 0.0005
902 CIRCULATORY COLLAPSE 9 0.0005
903 ACNE 40 0.0005
904 CARDIAC FAILURE CONGESTIVE 42 0.0005
905 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 27 0.0005
906 HERNIA 10 0.0005
907 ERUCTATION 10 0.0005
908 ECZEMA 27 0.0005
909 SYRINGE ISSUE 9 0.0005
910 CARDIOVASCULAR DISORDER 13 0.0005
911 RESPIRATORY DISTRESS 14 0.0005
912 SPINAL FRACTURE 10 0.0005
913 RASH MACULO-PAPULAR 11 0.0005
914 BONE DISORDER 9 0.0005
915 CHOLELITHIASIS 16 0.0005
916 BACTERIAL INFECTION 9 0.0005
917 DYSPNOEA EXERTIONAL 18 0.0005
918 HALLUCINATION, VISUAL 10 0.0005
919 HAEMORRHAGE 49 0.0005
920 MULTIPLE SCLEROSIS RELAPSE 32 0.0005
921 OCULAR HYPERAEMIA 22 0.0005
922 OXYGEN SATURATION DECREASED 26 0.0005
923 ORTHOSTATIC HYPOTENSION 8 0.0005
924 DERMATITIS ATOPIC 24 0.0005
925 AGITATION 33 0.0004
926 SKIN BURNING SENSATION 32 0.0004
927 CHROMATURIA 10 0.0004
928 BLOOD GLUCOSE ABNORMAL 8 0.0004
929 HAEMATOMA 11 0.0004
930 DISEASE RECURRENCE 20 0.0004
931 HYPOGLYCAEMIA 20 0.0004
932 PANCREATITIS ACUTE 9 0.0004
933 DRY SKIN 52 0.0004
934 SKIN ULCER 10 0.0004
935 RED BLOOD CELL COUNT DECREASED 11 0.0004
936 LIVER FUNCTION TEST ABNORMAL 11 0.0004
937 CELLULITIS 19 0.0004
938 PALLOR 10 0.0004
939 DEVICE BREAKAGE 14 0.0003
940 SKIN EXFOLIATION 29 0.0003
941 HIP FRACTURE 11 0.0003
942 BLOOD GLUCOSE DECREASED 16 0.0003
943 CORONARY ARTERY DISEASE 10 0.0003
944 FEMUR FRACTURE 10 0.0003
945 SUICIDE ATTEMPT 19 0.0003
946 PANCREATIC CARCINOMA 9 0.0003
947 DEEP VEIN THROMBOSIS 20 0.0003
948 SKIN IRRITATION 14 0.0003
949 PSYCHOTIC DISORDER 9 0.0003
950 RENAL DISORDER 14 0.0003
951 SEPSIS 33 0.0003
952 TARDIVE DYSKINESIA 8 0.0003
953 AGGRESSION 14 0.0003
954 ATRIAL FIBRILLATION 27 0.0003
955 COMA 13 0.0003
956 CARDIAC ARREST 22 0.0003
957 WHITE BLOOD CELL COUNT DECREASED 28 0.0003
958 SEPTIC SHOCK 11 0.0003
959 HYPERGLYCAEMIA 9 0.0002
960 ALANINE AMINOTRANSFERASE INCREASED 15 0.0002
961 TOXICITY TO VARIOUS AGENTS 39 0.0002
962 DRUG DOSE OMISSION 38 0.0002
963 HYPOXIA 8 0.0002
964 ABNORMAL BEHAVIOUR 9 0.0002
965 ASPARTATE AMINOTRANSFERASE INCREASED 12 0.0002
966 RESPIRATORY FAILURE 16 0.0002
967 BLOOD CREATININE INCREASED 14 0.0002
968 HYPONATRAEMIA 11 0.0002
969 LUNG NEOPLASM MALIGNANT 8 0.0002
970 GASTROINTESTINAL HAEMORRHAGE 16 0.0002
971 BLOOD GLUCOSE INCREASED 36 0.0002
972 PRODUCT SUBSTITUTION ISSUE 11 0.0002
973 CHRONIC KIDNEY DISEASE 14 0.0002
974 ANAEMIA 33 0.0002
975 INTERSTITIAL LUNG DISEASE 8 0.0002
976 PLEURAL EFFUSION 10 0.0002
977 THROMBOCYTOPENIA 18 0.0002
978 RENAL FAILURE 21 0.0002
979 EMOTIONAL DISTRESS 19 0.0002
980 COMPLETED SUICIDE 13 0.0002
981 PLATELET COUNT DECREASED 16 0.0001
982 ACUTE KIDNEY INJURY 22 0.0001
983 DRUG DEPENDENCE 23 0.0001
984 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 10 0.0001
985 CARDIAC FAILURE 11 0.0001
986 RENAL IMPAIRMENT 10 0.0001
987 DRUG ABUSE 9 0.0001
988 HAEMOGLOBIN DECREASED 9 0.0001
989 NEUTROPENIA 8 0.0001